4D Molecular Therapeutics

David Kirn - CEO, Co-founder, Chairman
David Kirn - CEO, Co-founder, Chairman
USA | Funding: $595M (+)

Website: https://www.4dmoleculartherapeutics.com/

4D Molecular Therapeutics is unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.